Comparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay (Q36753766)

16 August 2017

Comparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay (English)

1 reference

https://api.crossref.org/works/10.1128/AAC.35.5.903

16 August 2017

0 references

1 reference

10 December 2022

author name string

S. Chamberland

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1854172

10 December 2022

H. A. Kirst

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1854172

10 December 2022

W. L. Current

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1854172

10 December 2022

language of work or name

English

0 references

publication date

1 May 1991

1 reference

full work available at URL

16 August 2017

https://europepmc.org/articles/PMC245127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1854172

https://europepmc.org/articles/PMC245127?pdf=render

10 December 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1854172

https://journals.asm.org/doi/pdf/10.1128/AAC.35.5.903

10 December 2022

1 reference

https://api.crossref.org/works/10.1128/AAC.35.5.903

Antimicrobial Agents and Chemotherapy

10 December 2022

published in

1 reference

16 August 2017

35

1 reference

16 August 2017

5

1 reference

16 August 2017

903-909

1 reference

Spiramycin therapy of experimental toxoplasmosis in mice

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245127

New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245127

Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245127

Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245127

Effect of roxithromycin on acute toxoplasmosis in mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245127

In vitro assessment of antimicrobial agents against Toxoplasma gondii

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245127

AIDS commentary. Toxoplasmic encephalitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245127

In vivo synergism of roxithromycin (RU 965) and interferon against Toxoplasma gondii

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245127

Synergy between RU 28965 (roxithromycin) and human neutrophils for bactericidal activity in vitro

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245127

Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245127

In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245127

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245127

In vitro effects of folate inhibitors on Toxoplasma gondii

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245127

Intracellular accumulation of azithromycin by cultured human fibroblasts

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245127

Specific Labeling of IntracellularToxoplasma gondiiwith Uracil*

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245127

In vivo and in vitro activity of roxithromycin against Toxoplasma gondii in mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245127

In vitro measurement of the inhibitory effect of macrolides, lincosamides and synergestines on the growth of Toxoplasma gondii

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245127

Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245127

Spiramycin ; therapeutic value in humans. (author's transl)

5 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1854172

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Characterization of de novo folate synthesis in Pneumocystis carinii and Toxoplasma gondii: potential for screening therapeutic agents

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1854172

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.35.5.903

1 reference

release_4iyr4rbxmfe3dn3okvmpalfi2q

16 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4iyr4rbxmfe3dn3okvmpalfi2q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

16 August 2017

1 reference